Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Free Cash Flow Generation Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Free Cash Flow Generation Index of 0.23x as of December 2024. Free cash flow of CN¥20.78 Million represents 0% of operating cash flow (CN¥89.33 Million). Explore Guangdong Taienkang Pharmaceutical Co. L (301263) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. For the full cash flow conversion analysis, see Guangdong Taienkang Pharmaceutical Co. L cash flow conversion.
Annual Free Cash Flow Generation for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year Free Cash Flow Generation Index for Guangdong Taienkang Pharmaceutical Co. Ltd. Check cash flow reinvestment rate of Guangdong Taienkang Pharmaceutical Co. L to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥20.78 Million | CN¥89.33 Million | CN¥68.55 Million | ▲ +120.4% |
| 2023 | -1.14x | CN¥-106.48 Million | CN¥93.53 Million | CN¥200.01 Million | ▼ -387.5% |
| 2022 | 0.40x | CN¥58.94 Million | CN¥148.81 Million | CN¥89.88 Million | ▼ -36.9% |
| 2021 | 0.63x | CN¥75.38 Million | CN¥120.02 Million | CN¥44.65 Million | ▲ +143.2% |
| 2020 | 0.26x | CN¥32.41 Million | CN¥125.53 Million | CN¥93.12 Million | ▼ -70.8% |
| 2019 | 0.88x | CN¥66.61 Million | CN¥75.44 Million | CN¥8.83 Million | — |